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Abstract
Purpose—Heart failure is increasingly prevalent in the
elderly. Treatment of patients with heart failure aims at
improving their clinical condition, quality of life, prevent
hospital (re)admissions and reduce mortality. Unfortunately,
only a select group of heart failure patients with reduced
ejection fraction are eligible for Cardiac Resynchronization
Therapy where 30–40% remain non-responders and need left
ventricular support. The aim of this study is to investigate if a
shape memory alloy (SMA) is able to increase the ejection
fraction of a mono-chamber static heart model by 5%.
Methods—A pediatric ventilation balloon was used as a heart
model (mono-chamber). Flexinol, a SMA, was placed
around the heart model in multiple conﬁgurations and
activated using pulse width modulation techniques to deter-
mine inﬂuence of diameter and conﬁguration on volume
displacement. Furthermore, pressure within the heart model
was measured with a custom-made pressure sensor.
Results—SMA with a diameter of 0.38 mm, placed in a spiral
shape and activated with a duty cycle of 80% and a
frequency of 50/min gave the highest ejection fraction
increase of 3.5%.
Conclusions—This study demonstrated the feasibility of
volume displacement in a static heart model by activation
of SMA-wires. Conﬁguration, duty cycle, frequency, pulse
intervals and diameter were identiﬁed as important factors
affecting the activation of SMA-wires on volume displace-
ment. Future research should include the use of parallel
SMA-wires, prototype testing in dynamic or ex vivo bench
models.
Keywords—Shape memory alloy, Heart failure, Ejection
fraction, Cardiac support device, Design conﬁguration.
INTRODUCTION
Epidemiology and Current Practice
Heart failure (HF) is characterized by the ‘‘inability
of the heart to pump blood at an adequate volume’’26
and results in marked limitation of physical activity.
Over 6.5 million Americans have HF and increases by
46% in 2030.3 HF is an incurable, lethal disease, where
1 in 8 deaths are related to HF with a 5-year mortality
rate after diagnosis of HF of 50%.8 Also, HF is the
most expensive diagnosis for hospitalizations and 30-
day readmissions.6
Treatment of heart failure focuses on quality of life
improvement, prevention of hospital admissions and
aim to decrease mortality. For patients with a reduced
left ventricular ejection fraction (HFrEF) below 40%,
pharmacological treatment with angiotensin-convert-
ing enzyme inhibitors, beta-blockers and mineralo-
corticoid/aldosterone receptor antagonists improve
survival rates.19 To reduce the risk of sudden death,
implantation of an Implantable Cardioverter Deﬁb-
rillator is recommended. For symptomatic patients,
Cardiac Resynchronization Therapy (CRT) is indi-
cated for a select group of patients, yet over 30% of
patients are non-responders and do not beneﬁt from
this treatment.2 For patients with resistant symptoms,
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surgical implantation of a Left Ventricular Assist De-
vice (LVAD) or heart transplantation may be consid-
ered,19 despite drawbacks of infection of the external
battery driveline occurring up to 35%14,16 and an
increased risk for thrombogenicity and thrombosis.1
Technological Opportunities
Shape Memory Alloys (SMAs) are able to recover
their shape after unloading from a particular stimulus,
such as temperature.9 At high temperature, these
SMAs contract and reverts to its original state during
the cooling process.11 Application of SMAs in medical
practice, such as coronary stents, has continued to
emerge since its discovery in the early 1930s.17 SMAs
have effective strain generation up to 4%, with fatigue
between 4 and 8%, high strength to weight ratio, and
low operating voltage.15,20 Recently, the use of SMAs
in the treatment of heart failure in bench models gen-
erated considerable attention.12,23 A mechano-electric
artiﬁcial myocardial assist system using SMA-wires
augmented aortic ﬂow rate by 15% in a goat study.
Also, systolic left ventricular pressure was elevated by
7% under the cardiac output condition of 3L/min in
these goats.21
However, challenges remain with respect to energy
supply, relaxation times of SMAs and testing in real-
istic heart models.
In this demonstrator study, we investigate which
SMA designs, and which Pulse Width Modiﬁcation
(PWM) techniques are able to increase ejection frac-




A pediatric silicone resuscitation balloon (Laerdal
Benelux bv, Amersfoort, The Netherlands) was used as
a mono-chamber static model with a volume of
475 mL. Flexinol actuator wires (Dynalloy Inc., Ir-
vine, California, United States) were used as SMA.
Flexinol wires are composed of nickel-titanium alloy
(55wt%Ni, 45wt%Ti) with a diameter of 150, 250, and
380 lm respectively, displaying transformation tem-
FIGURE 1. Schematic representation of test setup. Pulse generator which activates the SMA around the heart model with three





peratures of 70 C. The density of Flexinol is 6.45 g/
cm3 with a heat capacity of 0.2 cal/g K and thermal
conductivity of 0.18 W/cm K.4,5 A detailed description
of nickel-titanium alloys can be found elsewhere.12 A
power supply and pulse generator were used to mea-
sure volume displacement after activation of SMAs
(Fig. 1). A skeleton composed of Flexinol wires, mi-
cro-tubes, vascular ties, rings and Velcro straps was
used based on the experimental setup of Shirashi
et al.15 and is depicted in Fig. 2a. Rings were posi-
tioned to distribute force more evenly over the balloon.
SMA wires were connected to small power cables by
cable shoe connectors and attached to screw terminals
for proper ﬁxation (Fig. 2b).
Design Conﬁgurations
Diﬀerent conﬁgurations of SMA-orientation were
evaluated, e.g. spiral, band, cross and oblique shaped
orientations (Fig. 3) at a frequency of 20/min. Volume
displacement was measured in a transparent open top
plastic tube (height 400 mm, diameter 8 mm), verti-
cally connected to the resuscitation balloon. Both
balloon and part of the vertical plastic tube were ﬁlled
with water (Fig. 2a). First two pulses were used to
warm-up the SMA-wire and stabilize the system.
Images were recorded with a compact camera,
processed by dedicated software using Kinovea 0.8.15
(France) where volume level was tracked as a function
of time for all design conﬁgurations. Displaced vol-
umes and corresponding ejection fractions were cal-
culated using Microsoft Excel 2016. Graphs were made
with GraphPad Prism 5 (GraphPad Software, Inc., San
Diego, CA, U.S.A.).
PWM techniques were used (Fig. 1) to alter pulse
frequency (50–90/min), duty cycle (20–80%) and pulse
intervals (1–5) to elicit maximal volume displacement
of a single SMA-wire.
Pressure Measurements
Pressure development was assessed within the
resuscitation balloon according to DP = p 9 g 9 h:
where p is density of the liquid kg/m3, g is gravitational
acceleration m/s2 and h is the height difference of the
liquid with respect to the initial situation. Pressure
development was measured in the resuscitation balloon
during the 5th pulse to minimize slope effects. Pressure
was controlled and recorded with an intravenous blood
pressure sensor (501669001, Merit OEM, the Nether-
lands) interlinked to a microcontroller (Arduino Uno,
Arduino), see Fig. 4. Raw data were ﬁltered with a
High-pass Butterworth ﬁlter and a Moving Average
ﬁlter (Matlab R2016b, MathWorks, Natick, USA).FIGURE 2. (a) Test setup with ventilation balloon as a heart
model; (b) detailed overview of heart model.
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Statistical Analysis
GraphPad Prism 5 was used to perform statistical
analysis. Results were considered statistically signiﬁ-
cant at the 5% level. A one-way ANOVA and a Tukey
post hoc test was used for experiments with different
SMA conﬁgurations and activation frequencies. A re-
peated measures ANOVA with a Tukey post hoc test
was used for experiments with different pulse intervals.
Results are reported as mean ± SD. Error bars rep-
resent 95% Conﬁdence Interval.
RESULTS
Design Conﬁgurations
SMA wires were applied onto the resuscitation
balloon in spiral, band, cross and oblique conﬁgura-
tions. Absolute volume displacement diﬀered signiﬁ-
cantly for peaks 3–7 between conﬁgurations,
ANOVA(F(3,16) = 652, p < 0.0001). A Tukey post
hoc test indicated signiﬁcant comparisons between all
designs (p < 0.0001) favoring spiral design, except for
spiral vs. band (p = 0.08, 95% CI  0.016 to 0.26), see
Fig. 5.
The inﬂuence of wire diameter on volume dis-
placement was studied for 150, 250, and 380 lm SMA
wires. Maximum volume displacement increased al-
most linearly with increasing number of windings
around the resuscitation balloon (r2 = 0.99) in these
wires (Fig. 6a). Volume displacement was signiﬁcantly
higher for the 380 lm wire (3.8 mL ± 1.6) as com-
pared to the 250 lm SMA wire (1.2 mL ± 0.6,
p < 0.05). A similar dependency was observed for the
required voltage (Fig. 6b).
Maximum absolute volume displacement in spiral
conﬁguration was 9.0 ± 0.18 cm H2O, equivalent to
6.9 ± 0.076 mmHg for pulses 3–5 (Fig. 7a). The cal-
culated pressure in the resuscitation balloon using our
pressure sensor was 7.1 ± 0.49 mmHg (Fig. 7b), not
statistically signiﬁcant (p = 0.54, 95% CI 5.9 to 8.3).
A band shaped conﬁguration with 5 windings resulted
in a pressure of 10.3 mmHg at an electric current
supply of 2.25 A. A current of 2.85 A in combination
FIGURE 4. Pressure sensor. (1) inflated Transcatheter Aortic Valve Implantation (TAVI) balloon; (2) external pressure sensor; (3)
manual pump with pressure gauge to fill TAVI-balloon with water; (4) connection to pressure sensor and microcontroller.
FIGURE 5. Design of SMA and effect on volume
displacement with mean and 95% CI of absolute volume
displacement (p < 0.0001 for all comparisons, except for





with assisting rings to distribute forces across the
resuscitation balloon, resulted in maximum volume
displacement of 16.4 mL. This corresponds to a pres-
sure build-up of 24.1 mmHg.
Pulse Width Modulation (PWM) Techniques
Volume displacement of every third pulse was
measured at diﬀerent frequencies with duty cycle kept
constant at 75% and pulse interval at 5 (1/5th of fre-
quency). Maximum displaced volume decreased sig-
niﬁcantly upon increasing pulse frequency,
ANOVA(F(4,25) = 400, p < 0.0001) (Fig. 8a).
Furthermore, volume displacement reached a con-
stant volume after 3 pulses, regardless of the employed
pulse frequency. A Tukey post hoc test revealed a sig-
niﬁcantly higher volume displacement for a frequency
of 50/min (1.6 mL ± 0.04, p < 0.05) as compared to
other frequencies. Both higher duty cycles and higher
electric currents increased volume displacement and
ﬂow (Figs. 8b and 8c). A duty cycle of 90 or 100%
would impair the cooling process and was not tested.
Volume displacement changed remarkedly each cy-
cle when supporting every heartbeat at a frequency of
60/min, as compared to other intervals. The SMA was
unable to return to its original state within this short
(a) (b)
FIGURE 6. Influence of SMA diameter and windings on (a) volume displacement and (b) power supply. A linear regression line is
drawn between data points (r2 = 0.99 in both graphs).
(a) (b)
FIGURE 7. Pressure development with (a) measured volume displacement (mm Hg) and (b) external pressure sensor (mm Hg).
(a) (b) (c)
FIGURE 8. Pulse Width Modulation (PWM) techniques and effect on volume displacement with (a) pulse frequency; (b) duty cycle;




Technical Feasibility and Design of a Shape Memory Alloy 5
cycle time as depicted in Fig. 9. A Tukey post hoc
correction revealed that absolute volume displacement
was statistically signiﬁcant different for an interval of 1
(2.0 mL ± 0.4) and the intervals 3 (1.4 mL ± 0.2,
p < 0.01), 4 (1.3 mL ± 0.1, p < 0.001) and 5
(1.2 mL ± 0.2, p < 0.001). There was no signiﬁcant
difference between interval 1 and 2 (1.8 mL ± 0.4,
p = 0.35).
DISCUSSION
In this study we investigated optimal design char-
acteristics of a demonstrator SMA support device for
HFrEF patients. A 380 lm SMA Flexinol wire con-
ﬁgured in a spiral oriented shape around a mono-
chamber balloon activated with a duty cycle of 80%, a
frequency of 50/min gave the highest volume dis-
placement (stroke volume, 6.2 mL). A maximum
ejection fraction (EF) of 3.5% was achieved, requiring
a power supply of 25 V and 2.85 A for each pulse.
Tozzi et al. used a 100 lm diameter SMA nitinol
wire with total stimulation of 180 ms, recovery time of
250 ms and contraction rate of 80/min.23 They
achieved a maximum ejected volume of 330 mL/min, a
generated systolic pressure of 75 mmHg, ejection
fraction of 12% requiring a power supply of 6 V and
250 mA.23 This is comparable to our maximum ejected
volume of 310 mL/min. In their experiments, a double-
chamber setup was used, with balloon volume of only
50 mL. This is much smaller than patients with
HFrEF22 making extrapolation of these results into a
physiological situation difﬁcult.
Diameter and Volume Displacement
Volume displacement and required voltage dis-
played a linear incremental relation in our experiment
with the employed number of SMA-wires (windings)
for all tested diameters (150, 250 and 380 lm),
(Fig. 6a and b). This may suggest that the number of
required SMA-wires for a speciﬁc volume displacement
and the corresponding voltage may be predicted. An
EF of 10% for this balloon (= 475 mL) would then
require 46 windings, although maximum strain of
SMAs might limit this linear behavior.
Thermal Management
A lower pressure build up was observed in the ﬁrst
contraction cycles (Figs. 7a and 7b). Joule heating
started the transformation phase but was not com-
pleted yet. After a few cycles temperature increased
and the transformation phase was completed.11 A
linear relationship between electric current increase
and volume displacement was observed by Velazquez
et al.24 Indeed, we observed that SMA wires had a
higher volume displacement when increasing electric
current (Fig. 8c). However, increasing electric currents
above the plateau phase as observed in Fig. 8c, may
cause overheating and induce stress fatigue. To reduce
heating of surrounding tissue, a silicone tube proved to
be effective in goat experiments.21 Indeed, Shiraishi
et al. found no major draw backs related to heat pro-
duction in silicone insulated SMA-wires in goats.21
Kalogerakos et al. found that insulated wires produced
a lower volume displacement than non-insulated
wires.12 Furthermore, cooling time is slower than
heating time and thus urges for interval use such as
once in four heart beats.
Pulse Width Modulation
Heart support during every heartbeat requires rapid
compression and expansion of the SMA. This may not
be directly attainable, though HF patients may already
beneﬁt from partial heart support. Hence the inﬂuence
of pulse width modulation on volume displacement
was investigated. SMA wires that were left to cool
down before the following activation step produced
substantially higher volume displacements (Fig. 9). In
our experiment, pulse intervals of every 3 or every 5
cycles gave higher volume displacements than pulse
intervals of every 1 or every 2 heart beats. A second,
lower peak (‘‘bounce’’) was absent with a pulse interval
of 1. Here, next activation occurred faster than cool-
down and recovery of the SMA wire.
In this demonstrator study, hourly energy con-
sumption of SMA activation ranged from 5.5 to 11.4
Watt-hour, where an increased energy use resulted in
higher ejection fractions. This range is lower than the
hourly energy consumption of 23.6 Watt-hour of a
FIGURE 9. Pulse interval and effect on volume
displacement. Volume displacement changes drastically
when every cycle (interval of 1) is supported in comparison





HeartMate II assist device25 and is comparable to
SMA-prototypes12 or HeartMate III at 11 Watt–
hour.18 At body temperature, SMA wires consume less
energy than bench temperature due to a reduction in
temperature gradient.10 This is promising for battery
size reduction and therefore reduces frequent change of
the (external) battery.
Limitations of Experimental Setup
A silicon pediatric resuscitation balloon was em-
ployed as a static model and acted as a mono-chamber
model with a large end-diastolic volume (EDV) of
475 mL. EDV in HFrEF-patients range from 100 to
300 mL, depending on ventricular dilatation.22 Thus,
this model underestimates effect size for clinical use.
Durability of SMAs for cardiac applications should
extend beyond patients life expectancy. In this study,
no change in volume displacement was observed after
25 min (Supplemental Fig. 1). Comparable SMAs were
tested in a fatigue lifetime test and assured constant
stroke after at least 106 cycles.7 However, for cardiac
applications these experiments should ensure SMA
stability over 108 cycles.
Also, afterload is reduced in LVAD therapy where
eﬀects of a SMA support device on afterload are still
unknown. These eﬀects should be addressed in future
experimental setups and should be within physiological
systemic aortal pressure.
Finally, energy consumption for achieving an ejec-
tion fraction of 3.5% was threefold higher than a
pacemaker. This might aﬀect future clinical use when
battery life is too short for internal battery use.
External battery use comes with an increased risk for
driveline infections and impair patients mobility.16 An
increase of parallel windings can reduce SMA length
and resistance, with a reduction in energy consumption
to follow.
FUTURE PERSPECTIVES
Future research should focus on evaluation of spiral
or oblique shaped conﬁgurations around the heart in
advanced bench models such as dynamic setups or an
ex vivo porcine cadaver model. The helical ventricular
myocardial band cardiac ﬁber orientation should be
acknowledged in these designs.13 This represents a
physiologically more realistic model than the proof of
principle in an in vitro mono-chamber bench model
presented here. Alternatively, a double-chamber bench
model with incorporated right ventricle can then in-
clude biventricular support. This should increase the
technology readiness level from 3 (Characteristic
Proof-of-Concept) to 4 (Proof-of-Concept in deﬁned
models). Furthermore, combining both different
afterload scenarios such as hypertension or mitral
regurgitation and design conﬁgurations in a mathe-
matical model might enhance device development.
Eﬀectivity of SMA-wire application may be objec-
tiﬁed with (ex vivo) Magnetic Resonance Imaging
(MRI) on segmental wall motion abnormalities. Also,
a mesh such as the CorCap Cardiac Support Device or
other supportive materials may be incorporated
around the heart in future designs to guide and support
SMA-wires and prevent dilatation of the left ventricle.
This would also prevent incising heart tissue with
SMA-wires. The resultant exoskeleton then prevents
occurrence of dead space between SMA-wires and
epicardium, thus giving additional support for effective
contraction and improved ejection fraction.
An increased stroke volume of 11.8 mL improve
patients New York Heart Association (NYHA) func-
tional class on heart failure symptoms by a class.12 Our
current setup might improve these symptoms by half a
class, which is not clinically relevant yet. Future studies
should aim to improve NYHA-class at least by one
and preferably by two classes.
CONCLUSIONS
Optimal design characteristics of a SMA support
device for HFrEF patients were determined in this
demonstrator study. A LVEF increase of 3.5% was
demonstrated in a mono-chamber static heart model
by activation of SMA-wires. Furthermore, eﬀects of
conﬁguration, duty cycle, frequency, pulse intervals
and diameter on the activation of SMA-wires and
corresponding volume displacement was evalu-
ated.Publisher’s NoteSpringer Nature remains neutral
with regard to jurisdictional claims in published maps
and institutional afﬁliations.
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